Topic Paragraphs
First Major Update to Infant Formula Standards in Nearly 30 Years

Trump Administration Announces First Major Update to Infant Formula Standards in Nearly 30 Years

 

Featured Topics

Recalls
Report a Problem
Warning Letters
Consumer Updates
483s
EUAs
510Ks
Guidance Documents
Drug Databases
Import Program

FDA in Action

Transparency Makes Modern Regulatory Science Stronger — FDA’s Transparency Roadmap
FDA Approves First Heart Valve Designed to Grow with Children
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
Supporting and Strengthening Domestic Drug Manufacturing
The FDA at 120: A Long, Distinguished History Protecting Americans
Accelerating and Modernizing Early and Late-Stage Clinical Development
Year 1 Goals in Reducing Animal Testing in Drug Development
Results from Largest-Ever Testing of Infant Formula in the U.S.
FDA PreCheck Pilot Program: Strengthening Domestic Pharmaceutical Manufacturing

Press Announcements

October 30, 2026

FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis

October 22, 2026

FDA Launches New Program to Advance Neuroscience Medical Product Development

October 20, 2026

FDA Issues Final Guidance on Prescription Drug Apps and Software

Products We Regulate

Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood, and Biologics
Animal and Veterinary
Cosmetics
Tobacco Products
Back to Top